These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis. Gupta AK; Stec N; Bamimore MA; Foley KA; Shear NH; Piguet V J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067 [TBL] [Abstract][Full Text] [Related]
4. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK; Gover MD; Lynde CW J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [TBL] [Abstract][Full Text] [Related]
5. Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study. Gupta AK; Venkataraman M; Bamimore MA Br J Dermatol; 2023 Jul; 189(1):12-22. PubMed ID: 37253047 [TBL] [Abstract][Full Text] [Related]
6. Topical and device-based treatments for fungal infections of the toenails. Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269 [TBL] [Abstract][Full Text] [Related]
7. Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure. Gupta AK; Daigle D; Paquet M J Am Podiatr Med Assoc; 2015 Jul; 105(4):357-66. PubMed ID: 25032982 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. Gupta AK J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137 [TBL] [Abstract][Full Text] [Related]
9. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Gupta AK; Ryder JE; Johnson AM Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329 [TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis. Jansen R; Redekop WK; Rutten FF Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756 [TBL] [Abstract][Full Text] [Related]
12. An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. Jaiswal A; Sharma RP; Garg AP Indian J Dermatol Venereol Leprol; 2007; 73(6):393-6. PubMed ID: 18032857 [TBL] [Abstract][Full Text] [Related]
13. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
14. Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis. Fávero MLD; Bonetti AF; Domingos EL; Tonin FS; Pontarolo R J Dermatolog Treat; 2022 Feb; 33(1):121-130. PubMed ID: 32043906 [TBL] [Abstract][Full Text] [Related]
15. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. Krob AH; Fleischer AB; D'Agostino R; Feldman SR J Cutan Med Surg; 2003; 7(4):306-11. PubMed ID: 14738099 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Gupta AK; Gregurek-Novak T Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230 [TBL] [Abstract][Full Text] [Related]
17. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany. Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348 [TBL] [Abstract][Full Text] [Related]
19. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK; Lynde CW; Konnikov N J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [TBL] [Abstract][Full Text] [Related]
20. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]